Global Nanoemulsion Market

Nanoemulsion Market size was valued at US$ 12.62 Bn. in 2025 and the total revenue is expected to grow at a CAGR of 8.80% through 2026 to 2032.

Nanoemulsion Market Overview:

The Nanoemulsion Market is expected to reach at US$ 20.72 Bn. by 2032. Nanoemulsions are colloidal particulate systems with submicron size particles that act as medication carriers. These carriers are solid spheres with an amorphous, lipophilic, negative-charged surface. To improve site specificity, magnetic nanoparticles can be utilised. The spontaneous emulsification method is used to make nanoemulsions (titration method). They are easily made by combining oil, water, surfactant, and cosurfactant in the proper proportions and agitating lightly.To know about the Research Methodology:-Request Free Sample Report

Market Dynamics:

The increasing burden of chronic diseases and the development of vaccines, as well as the growing acceptance of targeted medicines and image-guided therapies, and the high stability and chemical characteristics for efficient drug administration, all contribute to the market's growth.

Vaccines are important in the treatment of a variety of chronic and infectious diseases that have become more common in recent decades. Nanoemulsion formulations are being used by an increasing number of biopharmaceutical companies in the production of vaccines. BlueWillow Biologics Inc., a nanotechnology-based vaccine developer, reported in June 2021 that it had secured a US patent for its NanoVax intranasal anthrax vaccine. When delivered intranasally, the NanoVax nanoemulsion platform elicited both a systemic and mucosal response. Other traditional vaccinations, on the other hand, are administered (intramuscularly) and do not provide mucosal protection. Vaccines against two strains of genital herpes viruses, HSV1 and HSV2, have also been developed using the NanoVax technology.

The use of nanoemulsions as adjuvants for vaccines to treat chronic infections and cancer disorders through targeted therapy has shown promising outcomes in the recent decade. There are an increasing number of research projects being carried out by institutes in partnership with various government funds and enterprises, with the primary goal of improving the oral delivery of medications for the management of chronic diseases. The improved transdermal penetration of pharmaceuticals by nanoemulsion boosts the drug's plasma concentration profiles and bioavailability. In the case of cancer indications, the nanoemulsion and nanoparticle form has a larger potential for destroying cancer cells, as well as improved therapy of cancer, osteoarthritis, and fibromyalgia. Nanoemulsion applications are predicted to grow globally, driving the market, due to the continual demand for new and improved vaccines.

Market Segment Analysis:

Based on the Type, the market is segmented into Small-molecule Surfactant, Protein-stabilized Emulsions, and Polysaccharide. Small-molecule Surfactant segment is expected to hold the largest market shares of xx% by 2032. This is due to an increase in demand for small-molecule surfactants from a variety of food manufacturers. Nanotechnology is being used to make emulsions, which is a new trend in the food sector. Because it is the most recent in the business, the current manufacturing cost is extremely high. The cost of machinery used in nanoemulsion production can be reduced, and simpler and compact designs can be created. Local producers will be able to afford the technology and installation if the cost of the technology falls, and the market will expand domestically. Competitors can also experiment with new food-grade substances, which will provide many additional benefits and be beneficial to the food.

Based on the Application, the market is segmented into Anesthetics, Antibiotics, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immunosuppressants, Steroids, Beverage, Dairy, Bakery, and Other Applications. Antibiotics segment is expected to grow rapidly at a CAGR of xx% during the forecast period. Nanoemulsion formulations are becoming more clinically relevant because they offer a significant benefit over traditional antibiotic formulations. This is because administering medicines in nanoparticle form dramatically increases their antibacterial action. Nanoemulsions are widely employed in the delivery of antimicrobial drugs and serve a variety of functions. They can help with antibiotic administration via transdermal, topical, and oral routes by acting as effective carriers for antibiotic bioactivation. The use of nanoemulsion in antibacterial characteristics and efficient anti-biofilm agents is gaining popularity. This is expected to have a favourable impact on market growth throughout the forecast period.

Researchers and businesses all over the world are paying more attention to the rise in antibiotic resistance. However, the number of new antibiotics approved for therapeutic use against developing "superbugs" has been rather low. In 2025, the Asian Journal of Pharmaceutical Education and Research published a number of articles regarding nanoemulsions and their antibacterial properties, including an article regarding the stability and antibacterial properties of an oil-in-water nanoemulsion of erythromycin against Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. The companies that invest in the antibiotics segment are stable, with significant applications in a wide range of antibiotics for treating various diseases and the advent of better treatment options. As a result, the rate of success and adoption may have an impact on the market's growth during the forecast period.

Nanoemulsion Market Regional Insights:

North America region is expected to dominate the Nanoemulsion Market during the forecast period 2022-2029. North America region is expected to hold the largest market shares of xx% by 2032. This is due to the presence of major companies, the region's high prevalence of chronic diseases, and well-established healthcare infrastructure. Additionally, favourable government initiatives and a rise in the legalisation of cannabis-based products are expected to boost market growth in the region. Canada is quickly establishing itself as a major participant in this region. The cannabis sector in Canada is one of the world's largest. Pharmaceutical medicine companies that work in this field use nanoemulsions. Emerald Health Therapeutics Inc. developed a novel nanoemulsion-based Fast Action Spray product line containing nanoemulsion-infused cannabis in June 2021. In terms of convenience and predictability of intake, the new formulation outperforms existing cannabis consumption methods.

Pressure BioSciences Inc., based in Massachusetts, announced the launch of its Ultra Shear Technology Demonstration Laboratory in February 2021, which can transform CBD oil into high-quality, water-soluble nanoemulsions. The UST Demo Lab is housed in the company's South Easton, Massachusetts headquarters. The UST Demo Lab will look into ways to make hemp-derived cannabis oil more water soluble, as well as ways to improve absorption and bioavailability when it is taken or applied. The nanoemulsion market is expected to benefit from innovative product advancements by leading firms in this region.

Nanoemulsion Market Recent Development:

Competitive Matrix of the Nanoemulsion Market:

The objective of the report is to present a comprehensive analysis of the Global Nanoemulsion Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Nanoemulsion Market dynamic, structure by analyzing the market segments and project the Global Nanoemulsion Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanoemulsion Market make the report investor’s guide.

Nanoemulsion Market Scope: Inquire before buying

Nanoemulsion Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Nanoemulsion Market Key Players

1. Astellas Pharma Inc.
2. Biocodex SA
3. Dainippon Sumitomo Pharma Co. Ltd.
4. Eisai Co. Ltd.
5. Johnson & Johnson
6. Merck & Co. Inc.
7. Pfizer Inc.
8. Takeda Pharmaceutical Company Limited
9. Sanofi SA
10. Pernix Therapeutics Holdings Inc.
11. Neurim Pharmaceuticals Ltd.
12. Flynn Pharma Ltd.
13. SkyePharma PLC
14. AQUANOVA AG
15. DuPont Nutrition & Biosciences
16. Frutarom Industries Ltd.
17. Keystone Foods
18. Gattefossé SA
19. Croda International Plc
20. BASF SE
21. Evonik Industries AG
22. Lubrizol Corporation
23. Dow Inc.
24. Lipoid GmbH
25. ABITEC Corporation
26. Finar Limited
27. Tokyo Chemical Industry Co. Ltd. (TCI Chemicals)
28. Neuland Laboratories Ltd.
29. AkzoNobel N.V.
30. Fine Chemical Co. Ltd.

Others